Periodontal inflammatory burden and salivary matrix metalloproteinase-8 concentration among patients with chronic kidney disease at the predialysis stage

Journal of Periodontology

Volumn 86, Issue 11, 2015, Pages 1212-1220

  Nylund, Karita M ^a   Meurman, Jukka H ^a   Heikkinen, Anna Maria ^a   Honkanen, Eero ^a   Vesterinen, Maarit ^a   Furuholm, Jussi O ^a   Tervahartiala, Taina ^a   Sorsa, Timo ^b   Ruokonen, Hellevi M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Diabetes mellitus; Matrix metalloproteinase 8; Periodontal diseases; Renal insufficiency

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; NEUTROPHIL COLLAGENASE;

CHEMISTRY; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; HUMAN; INFLAMMATION; PERIODONTAL INDEX; PERIODONTAL POCKET; SALIVA;

DIABETIC NEPHROPATHIES; GLYCATED HEMOGLOBIN A; HUMANS; INFLAMMATION; MATRIX METALLOPROTEINASE 8; PERIODONTAL INDEX; PERIODONTAL POCKET; RENAL INSUFFICIENCY, CHRONIC; SALIVA;

EID: 84946098504     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2015.150285     Document Type: Article

References (41)

1. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: Current concepts. J Periodontol 1992;63(Suppl. 4): 322-331.
2. Linden GJ, Herzberg MC; Working group 4 of joint EFP/ AAP workshop. Periodontitis and systemic diseases: A record of discussions ofworking group 4 of the Joint EFP/ AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol 2013;40(Suppl. 14): S20-S23.
3. Eckardt K-U, Coresh J, Devuyst O, et al. Evolving importance of kidney disease: From subspecialty to global health burden. Lancet 2013;382: 158-169.
4. Cignarelli M, Lamacchia O. Obesity and kidney disease. Nutr Metab Cardiovasc Dis 2007;17: 757-762.
5. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005;365: 217-223.
6. Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update. Hypertension 1995;26: 869-879.
7. Fisher MA, Taylor GW, Shelton BJ, et al. Periodontal disease and other nontraditional risk factors for CKD. Am J Kidney Dis 2008;51: 45-52.
8. Rathnayake N, Akerman S, Klinge B, et al. Salivary biomarkers of oral health: A cross-sectional study. J Clin Periodontol 2013;40: 140-147.
9. Reynolds JJ, Meikle MC. Mechanisms of connective tissue matrix destruction in periodontitis. Periodontol 2000 1997;14: 144-157.
10. Ding Y, Haapasalo M, Kerosuo E, Lounatmaa K, Kotiranta A, Sorsa T. Release and activation of human neutrophil matrix metallo- and serine proteinases during phagocytosis of Fusobacterium nucleatum, Porphyromonas gingivalis and Treponema denticola. J Clin Periodontol 1997;24: 237-248.
11. Ding Y, Uitto VJ, Haapasalo M, et al. Membrane components of Treponema denticola trigger proteinase release from human polymorphonuclear leukocytes. J Dent Res 1996;75: 1986-1993.
12. Verma RP, Hansch C. Matrix metalloproteinases (MMPs): Chemical-biological functions and (Q)SARs. Bioorg Med Chem 2007;15: 2223-2268.
13. Sorsa T, Tjäderhane L, Salo T.Matrixmetalloproteinases (MMPs) in oral diseases. Oral Dis 2004;10: 311-318.
14. Sorsa T, Tjäderhane L, Konttinen YT, et al. Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38: 306-321.
15. Mäntylä P, Stenman M, Kinane D, et al. Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase- 8-specific chair-side test. J Periodontal Res 2006; 41: 503-512.
16. Sorsa T, Mäntylä P, Tervahartiala T, Pussinen PJ, Gamonal J, Hernandez M. MMP activation in diagnostics of periodontitis and systemic inflammation. J Clin Periodontol 2011;38: 817-819.
17. Leppilahti JM, Hernández-Ríos PA, Gamonal JA, et al. Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis. J Clin Periodontol 2014; 41: 348-356.
18. Leppilahti JM, Kallio MA, Tervahartiala T, Sorsa T, Mäntylä P. Gingival crevicular fluid matrix metalloproteinase-8 levels predict treatment outcome among smokers with chronic periodontitis. J Periodontol 2014;85: 250-260.
19. Leppilahti JM, Sorsa T, Kallio MA, et al. The utility of gingival crevicular fluid matrix metalloproteinase-8 response patterns in prediction of site-level clinical treatment outcome. J Periodontol 2015;86: 777-787.
20. Nwhator SO, Ayanbadejo PO, Umeizudike KA, et al. Clinical correlates of a lateral-flow immunoassay oral risk indicator. J Periodontol 2014;85: 188-194.
21. Kuula H, Salo T, Pirilä E, et al. Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis. Infect Immun 2009;77: 850-859.
22. Hernández M, Gamonal J, Salo T, et al. Reduced expression of lipopolysaccharide-induced CXC chemokine in Porphyromonas gingivalis-induced experimental periodontitis in matrix metalloproteinase-8 null mice. J Periodontal Res 2011;46: 58-66.
23. Basu RK, Donaworth E, Siroky B, Devarajan P, Wong HR. Loss of matrix metalloproteinase-8 is associated with worsened recovery after ischemic kidney injury. Ren Fail 2015;37: 469-475.
24. Buduneli E, Mäntylä P, EmingilG, et al. Acutemyocardial infarction is reflected in salivary matrix metalloproteinase- 8 activation level. J Periodontol 2011;82: 716-725.
25. Vesterinen M, Ruokonen H, Furuholm J, Honkanen E, Meurman JH. Oral health in predialysis patients with emphasis on diabetic nephropathy. Clin Oral Investig 2011;15: 99-104.
26. Nylund K, Meurman J, Heikkinen AM, Honkanen E, Vesterinen M, Ruokonen H. Oral health in predialysis patients with emphasis on periodontal disease. Quintessence Int 2015;in press.
27. Gursoy UK, Könönen E, Pradhan-Palikhe P, et al. Salivary MMP-8, TIMP-1, and ICTP asmarkers of advanced periodontitis. J Clin Periodontol 2010;37: 487-493.
28. Hemmilä I, Dakubu S, Mukkala V-M, Siitari H, Lövgren T. Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 1984;137: 335-343.
29. Page RC, Eke PI. Case definitions for use in populationbased surveillance of periodontitis. J Periodontol 2007; 78(Suppl. 7): 1387-1399.
30. Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction. BMJ 1989;298: 779-781.
31. Lindy O, Suomalainen K, Mäkelä M, Lindy S. Statin use is associated with fewer periodontal lesions: A retrospective study. BMC Oral Health 2008;8: 16.
32. Heikkinen AM, Sorsa T, Pitkäniemi J, et al. Smoking affects diagnostic salivary periodontal disease biomarker levels in adolescents.J Periodontol 2010;81: 1299-1307.
33. Rathnayake N, Akerman S, Klinge B, et al. Salivary biomarkers for detection of systemic diseases. PLoS One 2013;8: e61356.
34. Sorsa T, Gursoy U, Nwhator S, et al. Analysis of matrix metalloproteinase-8 specific chair-side test for monitoring periodontal diseases. Periodontol 2000 2015;in press.
35. Furuholm J, Sorsa T, Qvarnström M, et al. Salivary matrix metalloproteinase-8 in patients with and without coronary heart disease may indicate an increased susceptibility to periodontal disease. J Periodontal Res 2006;41: 486-489.
36. Chapple ILC, Genco R; Working group 2 of the joint EFP/AAP workshop. Diabetes and periodontal diseases: Consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol 2013;84(Suppl. 4): S106-S112.
37. Yokota T, Osanai T, Hanada K, et al. Effects of telmisartan on markers of ventricular remodeling in patients with acute myocardial infarction: Comparison with enalapril. Heart Vessels 2010;25: 460-468.
38. Guan W, Kozak A, Fagan SC. Drug repurposing for vascular protection after acute ischemic stroke. Acta Neurochir Suppl (Wien) 2011;111: 295-298.
39. Ducharme A, Frantz S, Aikawa M, et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 2000;106: 55-62.
40. Kadoglou NPE, Sailer N, Fotiadis G, Kapelouzou A, Liapis CD. The impact of type 2 diabetes and atorvastatin treatment on serum levels of MMP-7 and MMP-8. Exp Clin Endocrinol Diabetes 2014;122: 44-49.
41. Sorsa T, Hernández M, Leppilahti J, Munjal S, Netuschil L, Mäntylä P. Detection of gingival crevicular fluid MMP-8 levels with different laboratory and chair-side methods. Oral Dis 2010;16: 39-45.